The levonorgestrel-releasing intrauterine system (LNG-IUS) can provide a cost-effective alternative to hysterectomy for women with menorrhagia, according to a recent controlled trial reported in JAMA.
Finnish researchers randomized 236 women with a mean age of 43 years and menorrhagia to treatment with either the LNG-IUS or hysterectomy. After 5 years of follow-up, the two groups did not differ substantially in either health-related quality of life or psychosocial well-being. Satisfaction with treatment was similar in both groups. While 42% of the LNG-IUS group eventually received hysterectomy, after 5 years direct and indirect costs in the LNG-IUS group remained about 40% lower than for the hysterectomy group.
Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA. 2004;291:1456-1463.
Balancing VTE and bleeding risks in gynecologic cancer surgeries
December 6th 2024A comprehensive analysis shows the benefits of thromboprophylaxis often outweigh the bleeding risks during gynecologic cancer procedures, though patient-specific risk factors are crucial for decision-making.
Read More
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More